BIOXYTRAN, INC (BIXT)

↓ Download CSV

CIK 0001445815 · OTC · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31
Metric (FY)2025202420232022202120202019201820172016
Revenue$191.1K$246.5K
Cost of Revenue$104.0K$96.3K
Gross Profit$87.1K$150.2K
Operating Income-$1.84M-$2.22M-$3.80M-$2.44M-$4.21M-$1.27M-$1.63M-$215.1K-$310.6K-$671.3K
Net Income-$2.12M-$2.37M-$4.47M-$2.47M-$4.03M-$2.54M-$1.86M-$296.4K-$318.4K-$696.8K
EPS (Diluted)$-0.02$-0.02$-0.03$-0.02$-0.04
Total Assets$658.6K$138.7K$139.4K$370.9K$119.3K$326.4K$219.6K$36.4K$110$51.7K
Total Liabilities$3.25M$1.93M$3.24M$3.67M$3.28M$2.27M$1.02M$261.7K$1.4K$342.3K
Shareholders' Equity-$2.59M-$1.79M-$3.10M-$3.30M-$3.16M-$1.94M-$799.3K-$225.3K-$1.3K
Cash & Equivalents$11.1K
Operating Cash Flow-$526.5K-$381.3K-$775.4K-$1.80M-$1.70M-$1.10M-$431.0K-$185.9K-$18.5K-$42.4K
Shares Outstanding108.15M86.78M144.64M123.35M110.84M97.45M86.48M85.10M85.10M28.17M